These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7602466)

  • 1. In-vivo and in-vitro correlation for delayed-release behaviour of a molsidomine/O-carboxymethyl-O-ethyl-beta-cyclodextrin complex in gastric acidity-controlled dogs.
    Horikawa T; Hirayama F; Uekama K
    J Pharm Pharmacol; 1995 Feb; 47(2):124-7. PubMed ID: 7602466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peracylated beta-cyclodextrins as novel sustained-release carriers for a water-soluble drug, molsidomine.
    Uekama K; Horikawa T; Yamanaka M; Hirayama F
    J Pharm Pharmacol; 1994 Sep; 46(9):714-7. PubMed ID: 7837039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-carboxymethyl-O-ethylcyclomaltoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dog.
    Uekama K; Horiuchi Y; Irie T; Hirayama F
    Carbohydr Res; 1989 Oct; 192():323-30. PubMed ID: 2611776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of stability and bioavailability of 1-hexylcarbamoyl-5-fluorouracil (HCFU) by O-carboxymethyl-O-ethyl-beta- cyclodextrin].
    Horiuchi Y; Hirayama F; Uekama K
    Yakugaku Zasshi; 1991 Oct; 111(10):592-9. PubMed ID: 1812279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.
    Horiuchi Y; Hirayama F; Uekama K
    J Pharm Sci; 1990 Feb; 79(2):128-32. PubMed ID: 2324960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
    Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
    Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of a novel slow release preparation of molsidomine.
    Rietbrock S; Keller-Stanislawski B; Thürmann P; Brockmeier D
    Eur J Clin Pharmacol; 1992; 43(3):273-6. PubMed ID: 1425891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
    Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
    J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs.
    Wang Z; Hirayama F; Uekama K
    J Pharm Pharmacol; 1994 Jun; 46(6):505-7. PubMed ID: 7932048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].
    Hirayama F
    Yakugaku Zasshi; 1993 Jun; 113(6):425-37. PubMed ID: 8355145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Dissolution Studies of Amiodarone Hydrochloride From Hydroxy-Propyl-β-Cyclodextrin/Amiodarone Inclusion Complex Formulated Into Modified-Release Tablets.
    Creţeanu A; Ochiuz L; Vieriu M; Panainte AD; Ţântaru G
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):715-9. PubMed ID: 30152660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.
    Li J; Yang L; Ferguson SM; Hudson TJ; Watanabe S; Katsuma M; Fix JA
    AAPS PharmSciTech; 2002; 3(4):E33. PubMed ID: 12916927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose.
    Wang Z; Horikawa T; Hirayama F; Uekama K
    J Pharm Pharmacol; 1993 Nov; 45(11):942-6. PubMed ID: 7908033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
    Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrier.
    Uekama K; Matsubara K; Abe K; Horiuchi Y; Hirayama F; Suzuki N
    J Pharm Sci; 1990 Mar; 79(3):244-8. PubMed ID: 2338635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of silica carrier for controlled release of molsidomine: effect of preparation methods of silica matrixes and their composites with molsidomine on the drug release kinetics in vitro.
    Parfenyuk EV; Dolinina ES
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1038-45. PubMed ID: 25269886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel Delivery System for Cardiovascular Drug Molsidomine: Influence of Synthesis Method and Conditions on Molsidomine Release From Its Composites With Hydrophilic Silica In Vitro.
    Dolinina ES; Parfenyuk EV
    J Pharm Sci; 2016 Jun; 105(6):1952-1959. PubMed ID: 27238492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
    Hirayama F; Minami K; Uekama K
    J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.